Covid-19 Diagnostics Market to Generate $445.4 Million by the end of 2020: AMR

Rise in number of covid-19 patients worldwide and unavailability of particular medicine or vaccine drive the growth of the global covid-19 diagnostics market. Europe held more than half of the total market share in the first quarter of 2020. There are several trials for vaccine and treatments have been conducted by researchers across the globe, no cure has been found yet.


Portland, OR, June 12, 2020 (GLOBE NEWSWIRE) -- According to the reportby Allied Market Research, the global covid-19 diagnostics market garnered $7.1 million in the first quarter of 2020, and is estimated to generate $445.4 million by the fourth quarter of 2020.The report provides a detailed analysis of changing market trends, major winning strategies, investment pockets, key segments, and competitive landscape.

Rise in number of covid-19 patientsworldwide, surge in need of rapid diagnostics, and unavailability of particular medicine or vaccine drive the growth of the global covid-19 diagnostics market. However, lack of awareness in developing nations about necessary precautions and scarcity of diagnostic kits and medical professionals hinder the market growth. However, investment of leading manufacturers in developing advanced diagnostic kits would offer multiple opportunities in the near future.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6479

Covid-19 Impact:

  • There are several trials for boosters and treatments have been conducted by researchers across the globe, no cure has been found yet. Lack of availability of particular medicine or vaccine outlined the significance of the covid-19 diagnostic tools.
  • Researchers have broken the deadlock related to testing and diagnostic checks have been carried out. The results highlighted the population that need to be prioritized for immunization.

On the basis of technology, the report offers segmentation of the global covid-19 diagnostics market into molecular and immune assay. The molecular segment contributed the highest revenue in the first quarter of 2020, and will maintain the highest contribution by the fourth quarter of 2020. This is due to the fact that molecular assay being regarded as the gold standard for detection of new viral infections.

Based on end-user, the report segments the global covid-19 diagnostics market into physician offices & urgent care clinics, hospitals, and diagnostic labs. The diagnostic labs segment accounted for more than two-thirds of the total market share in the first quarter of 2020, and will maintain its dominant positionby the end of 2020.

Based on region, Europe held more than half of the total market share in the first quarter of 2020, and is estimated to continue its lead by the fourth quarter of 2020. This is attributed toconsiderable increase in number of patients in the province. The report is also analyzed across Asia-Pacific, LAMEA, and North America.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6479

Leading players of the global covid-19 diagnostics market analyzed in the report include F. Hoffmann-La Roche AG, Cepheid, Seegene Inc., SureScreen Diagnostics Ltd, MylabLifesolutions Pvt. Ltd., Genematrix, Thermo Fisher Scientific, Inc., Cellex Inc., and Robert Bosch GmbH.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

Similar Reports:

Molecular Diagnostics Market:Global Opportunity Analysis and Industry Forecast, 2017-2023

Womens Health Diagnostics Market - Global Opportunities and Industry Forecasts, 2017-2023

Home Care Monitoring and Diagnostics Market- Global Opportunity Analysis and Industry Forecast, 2020-2027

Serological Transplant Diagnostics Market- Global Opportunity Analysis and Industry Forecast, 2020-2027

 About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

 

Contact Data